助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[12]条 当前为第1条到12条
 

相关语句
two groups before and after treatment
    1 The comparison of the depressive total mark between the patients in the two groups before and after treatment: It significantly decreased after treatment compared with before treatment in acupuncture group and after treatment in control group[33.40±7.71, 52.70±6.80, 39.58±8.50 (t=7.91, 7.61, P < 0.05)].
    ①两组患者治疗前后抑郁总分比较:针刺组治疗后较治疗前、对照组治疗后显著降低33.40±7.71,52.70±6.80,39.58±8.50(t=7.91,7.61,P<0.05)。
    ①In the comparison of blood lipid level between the two groups before and after treatment At 3 and 6 weeks after treatment the level of total cholesterol triglycerides and LDL-C was significantly decreased as compared with before treatment in the two groupsP < 0.05 to 0.01 At 6 weeks after treatment HDL-C was significantly increased as compared with before treatment in the two groupsP < 0.01.
    ①两组患者治疗前后血脂水平的比较:在用药第3,6周后,两组患者血清总胆固醇、三酰甘油、低密度脂蛋白胆固醇水平均较用药前显著降低(P<0.05~0.01),用药第6周后两组患者的血清高密度脂蛋白胆固醇水平均显著高于用药前(P<0.01)。
    ③ Modified Barthel index in the two groups before and after treatment.
    ③两组患者治疗前后改良Barthel指数。
    ② Comparison of data of the linguistic intelligence quotient, operation intelligence quotient and total intelligence quotient of patients in the two groups before and after treatment: Before treatment the data in the yizhi capsule group was basically the same as that in the control group (P > 0.05).
    ②两组患者治疗前后言语智商、操作智商、全智商数据比较:治疗前益智胶囊组和对照组基本一致(P>0.05)。
    Changes in liver function (ALT, GGT, TBIL and ALB), AFP, T-lymphocyte subsets (CD_4, CD_4/CD_8) and iconological examination were observed in the two groups before and after treatment to compared the efficacy.
    观察两组患者治疗前后肝功能(ALT、GGT、TBIL、ALB)、AFP值、CD4、CD4/CD8值及肝脏影像学检查情况,比较各组治疗效果。
    1 Changes of bone density in patients of the two groups before and after treatment: It was higher in the Gusongkang group after treatment than that before treatment, and the difference had obvious significance (0.764±0.126) and (0.616±0.128)g/cm2;
    ①两组患者治疗前后骨密度变化:骨松康组治疗后高于治疗前,差异有显著性意义[(0.764±0.126)和(0.616±0.128)g/cm2;(t=5.92,P<0.001)]。
    MAIN OUTCOME MEASURES: ① Scores of NDS in the two groups before and after treatment;
    主要观察指标:①两组患者治疗前后临床神经功能缺损评分。
    ② Scores of FMA in the two groups before and after treatment;
    ②两组患者治疗前后Fugl-Meyer运动功能评分。
    ②Scores on functional activityself-care activity and ADL were compared in the patients of the two groups before and after treatmentand the difference had significant meaningP < 0.05.
    ②两组患者治疗前后功能活动、自理活动、日常生活活动总分比较,差异有显著性意义(P<0.05);
    We compared assessment score of dysphagia by VFSS (videofluoroscopic swallowing study), and observed serum potassium, sodium, albumin levels and the incidence of inhalation-pneumonia in two groups before and after treatment.
    采用吞咽X线透视检查法(VFSS)对两组患者治疗前后吞咽障碍进行评分,并检查血钠、钾、白蛋白水平及吸入性肺炎发生情况。
    The control group was treated only with meloxicam and sulfasalazine. The changes of both clinical and experimental indexes of two groups before and after treatment were analyzed.
    对照组仅给予美洛昔康和柳氮磺吡啶,观察两组患者治疗前后相关临床和实验室指标的变化。
    The blood pressure had no significant change in the two groups before and after treatment.
    两组患者治疗前后血压无显著变化。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社